The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
TANILONE (Aspen Pharmacare Australia Pty Ltd)
Product name
TANILONE
Date registered
Evaluation commenced
Decision date
Approval time
125 (255 working days)
Active ingredients
Methylprednisolone aceponate
Registration type
New generic medicine
Indication
TANILONE fatty ointment is indicated for the topical treatment of eczema and psoriasis in adults and children.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine